Himisha Beltran, MD
Principal Investigator
Dr. Beltran is a medical oncologist and physician scientist focused on understanding mechanisms of treatment resistance in prostate cancer and lineage plasticity during cancer evolution. She is an Associate Professor of Medicine in the Department of Medical Oncology in the Lank Division of Genitourinary Oncology and the Division of Molecular and Cellular Oncology at Dana-Farber Cancer Institute and Harvard Medical School. Her lab has specifically focused on the mechanisms underlying the development of neuroendocrine prostate cancer, an aggressive subtype of advanced prostate cancer. Dr. Beltran is also the Correlative Science Committee Chair for the Alliance for Clinical Trials in Oncology GU Committee and plays an active role in several national and international committees and programs including ASCO, ESMO, as well as team science projects such as the SU2C-PCF Dream Team and PCF SELECT. She serves as Director of Translational Research with Medical Oncology at Dana-Farber Cancer Institute, Director of the PROFILE program, Co-Director of the Center for Cancer Genomics (CCG), and co-PI of the DF/HCC Prostate Cancer SPORE. Dr. Beltran works closely with a multidisciplinary team to translate new scientific discoveries into the clinic in the form of biomarker-driven therapeutics to improve patient care.
Select Honors
- Elected Member, American Society for Clinical Investigation (ASCI)
- Helen Trailblazers Award, Helen Gurley Brown Foundation
- Alliance Scholar Award in Honor of Dr. Emil "Tom" Frei III
- Damon Runyon Cancer Research Foundation Clinical Investigator Award
- Prostate Cancer Foundation Young Investigator Award (Class of 2010)
Publications: Please visit here.